PROGRAM FOR THE STUDY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CELL THERAPIES IN HEMATOLOGIC MALIGNANCIES
In honor of Mechtild Harf, this program is intended to provide research grants to promising and developing researchers to advance the understanding of complications and therapeutic strategies in context of hematopoietic cell transplantation and/or cellular therapies for hematologic malignancies. The program is funded by the DKMS Foundation for Giving Life and administered by the DKMS gGmbH.
The submission period for 2020 is now open!Apply now
The Mechtild Harf Research Program provides four grants consisting of a maximum of € 240,000 made available over a period of three years (maximum € 80,000 annually), subject to adequate progress of the research. Each funding period runs from July 1st to June 30th. Grant awardees will be selected from among the eligible applications.RESEARCH SCOPE
The research proposal must address issues of hematopoietic transplantation and/or cell therapies for hematologic malignancies. These studies can range from cellular to pre-clinical animal models to human studies including co-funded clinical trials.